Key Takeaways
- Several important screenings — including cholesterol, colorectal, and skin checks — are routinely skipped by women.
- Many serious conditions, including cardiovascular disease and early-stage cancers, develop without noticeable symptoms.
- Screening frequency depends on individual risk factors, family history, and life stage — a clinician can personalize your schedule.
- Delaying screenings allows conditions to progress to stages that are harder and more complex to manage.
- Proactive screening is one of the most effective tools women have for protecting long-term health.
The Screenings Women Quietly Skip
Most women are familiar with cervical screenings and mammograms. But beyond those well-publicized tests, a meaningful cluster of preventive screenings is consistently underutilized by women — not out of negligence, but often because they receive less clinical attention, face more misconceptions, or simply aren't raised during routine appointments.
As the evidence on symptom-free disease progression makes clear, waiting to feel unwell before seeking evaluation is a structural gap in how many people approach their own health. Conditions such as high cholesterol, colorectal cancer, and skin malignancies can develop silently for years — and screening is specifically designed to find them before symptoms emerge.
The list below covers six screenings that women in various life stages frequently delay or overlook, along with the real risks of doing so. This content is general health information, not personal medical advice. Always consult a qualified healthcare provider to determine which screenings are appropriate for your individual situation.
Lipid Panel (Cholesterol Screening)
Cardiovascular disease is the leading cause of death among women in the United States, yet women are less likely than men to receive timely cholesterol evaluation. The U.S. Preventive Services Task Force (USPSTF) recommends lipid screening for women at elevated cardiovascular risk, and guidelines from major cardiology organizations support routine assessment beginning in midlife for average-risk women.
One reason this test is skipped: many women assume heart disease is primarily a male concern. But estrogen's cardioprotective effects diminish significantly after menopause, and risk rises sharply in the years that follow. High LDL cholesterol typically causes no symptoms, which is precisely why testing matters. See our dedicated overview on cholesterol and blood pressure monitoring in women for more context on what these numbers mean.
Heart disease is the leading cause of death in women — yet cholesterol screening remains widely underutilized.
Colorectal Cancer Screening
Colorectal cancer is the second leading cause of cancer death in the United States when men and women are combined, and women are not exempt from that risk. Current USPSTF guidelines recommend that average-risk adults begin colorectal cancer screening at age 45. Despite this, rates among women lag behind recommended levels.
Multiple screening modalities exist — including colonoscopy, stool-based DNA tests, and sigmoidoscopy — and the right choice depends on individual risk, preference, and clinical factors. Women with a family history of colorectal cancer or polyps, or conditions such as inflammatory bowel disease, may need to begin screening earlier. Delaying or avoiding this test allows polyps — which are almost always asymptomatic in early stages — to potentially progress undetected.
Colorectal cancer screening is recommended from age 45, yet many women delay it without a clear reason.
Full-Body Skin Examination
Melanoma, the most dangerous form of skin cancer, is diagnosed in tens of thousands of women each year in the U.S. While men have historically had higher melanoma mortality, younger women have shown higher incidence rates in some age groups — a pattern researchers link partly to indoor tanning behavior and sun exposure patterns.
Dermatologist-performed full-body skin exams can identify suspicious lesions at highly treatable early stages. The USPSTF notes insufficient evidence to recommend universal screening for average-risk adults, but clinical judgment — particularly for those with a history of sunburns, multiple moles, fair skin, or family history of skin cancer — often warrants periodic professional examination. Women should also perform regular self-checks and report changes to a provider promptly.
Early-stage melanoma is highly treatable — yet many women have never had a professional skin examination.
Bone Density Screening (DEXA Scan)
Osteoporosis affects an estimated 10 million Americans, with women comprising approximately 80% of cases. Despite this, bone density testing is often not discussed until a woman has already experienced a fracture — by which point significant bone loss has already occurred.
USPSTF recommends bone density screening via DEXA (dual-energy X-ray absorptiometry) scan for women aged 65 and older, and for postmenopausal women under 65 whose fracture risk equals that of a 65-year-old white woman. Factors such as early menopause, low body weight, smoking, corticosteroid use, or family history may make earlier screening appropriate. Our related article on bone density and osteoporosis risk explores this timeline in detail.
Osteoporosis develops silently for years — a DEXA scan can detect bone loss before a fracture occurs.
Blood Glucose and Prediabetes Screening
The CDC estimates that more than 1 in 3 American adults has prediabetes, and the majority are unaware of it. USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who are overweight or have obesity. Women with a history of gestational diabetes face a significantly elevated lifetime risk of developing type 2 diabetes and should be screened regularly after pregnancy.
Prediabetes is largely reversible through lifestyle modification when identified early. Yet without screening, it progresses to type 2 diabetes silently. Women who feel generally healthy often deprioritize this test — particularly if they don't identify with common risk stereotypes — making proactive scheduling all the more important.
Most people with prediabetes are unaware they have it — screening offers a genuine window for intervention.
Anxiety and Depression Screening
Mental health screening is often overlooked in a list of preventive tests, yet clinical guidelines support it firmly. The USPSTF recommends screening for anxiety disorders in adults under 65, and for depression in all adults. Women are diagnosed with depression at roughly twice the rate of men, and hormonal transitions — puberty, postpartum, perimenopause — represent periods of heightened vulnerability.
Brief validated tools like the PHQ-9 and GAD-7 can be administered in a primary care setting in minutes. Many women do not raise mental health concerns proactively during appointments, and many providers do not routinely screen without prompting. Normalizing these screens as part of a standard annual visit — not a crisis response — is a meaningful step toward closing this gap. See our overview on underaddressed reproductive and mental health conversations for related context.
Mental health screening is a recommended preventive tool — not something to wait for a crisis to initiate.
Making Screenings a Non-Negotiable Priority
Understanding which screenings exist is only part of the challenge — the harder part is consistently booking and attending them. Our decade-by-decade preventive care checklist can help you map out what to prioritize by age and life stage. If you've been deferring any of the screenings covered in this article, the most practical step is a frank conversation with your primary care provider or OB-GYN about what your personal timeline should look like.
Use Your Annual Visit Strategically
An annual well-woman visit is one of the most efficient opportunities to audit your screening history. Before the appointment, write down the last date you had each screening covered in this article. Share that list with your provider and ask directly whether you're overdue. A few minutes of preparation can unlock a more productive, personalized conversation about your preventive care timeline.
It's also worth recognizing that screening gaps aren't always the result of avoidance. Systemic barriers — including limited access to care, cost concerns, and gaps in provider communication — play a real role. If any of these are factors for you, community health centers and federally qualified health programs may offer low-cost or no-cost screening options worth exploring.
This article is for general informational and educational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for guidance specific to your health history and circumstances.